CCL Industries acquires CSI

3 March 2020

CCL Industries Inc. has announced the acquisition of Clinical Systems, Inc (“CSI”), a specialized provider to the United States clinical trials industry.

CSI, a label producer based in Garden City, NY, USA, specializes in patient information booklets and has developed a new software driven “eLabel” product for clinical trials providers. The enterprise value of the transaction, net of cash and debt, is approximately $19.4 million. Sales for the 12 months ending December 31, 2019, are approximately $14.4 million with an estimated adjusted EBITDA of $3.5 million.

CSI will be integrated into CCL Label’s Healthcare & Specialty operations and immediately begin trading as CCL Clinical Systems.

Geoffrey Martin, president and chief executive officer, of CCL Industries, says, “This transaction significantly expands our capabilities in the clinical trials space, providing new software and opportunities to expand internationally.”



Privacy Policy
We have updated our privacy policy. In the latest update it explains what cookies are and how we use them on our site. To learn more about cookies and their benefits, please view our privacy policy. Please be aware that parts of this site will not function correctly if you disable cookies. By continuing to use this site, you consent to our use of cookies in accordance with our privacy policy unless you have disabled them.